title: Tranylcypromine discontinuation symptoms and withdrawal delirium.
authors.forename: Roland W
authors.initials: RW
authors.lastname: Freudenmann
authors.forename: Eik
authors.initials: E
authors.lastname: Baumgarten
authors.forename: Andreas E
authors.initials: AE
authors.lastname: Hawlik
authors.forename: Carlos
authors.initials: C
authors.lastname: Schönfeldt-Lecuona
authors.forename: Maximilian
authors.initials: M
authors.lastname: Gahr
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000209:etiology*; D014191:Tranylcypromine / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine